151 related articles for article (PubMed ID: 23867360)
1. Small structural differences of targeted anti-tumor toxins result in strong variation of protein expression.
Gilabert-Oriol R; Thakur M; Weise C; Dernedde J; von Mallinckrodt B; Fuchs H; Weng A
Protein Expr Purif; 2013 Sep; 91(1):54-60. PubMed ID: 23867360
[TBL] [Abstract][Full Text] [Related]
2. Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners.
Tran M; Henry RE; Siefker D; Van C; Newkirk G; Kim J; Bui J; Mayfield SP
Biotechnol Bioeng; 2013 Nov; 110(11):2826-35. PubMed ID: 23719862
[TBL] [Abstract][Full Text] [Related]
3. Structure/function studies on two type 1 ribosome inactivating proteins: Bouganin and lychnin.
Fermani S; Tosi G; Farini V; Polito L; Falini G; Ripamonti A; Barbieri L; Chambery A; Bolognesi A
J Struct Biol; 2009 Nov; 168(2):278-87. PubMed ID: 19616098
[TBL] [Abstract][Full Text] [Related]
4. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
[TBL] [Abstract][Full Text] [Related]
5. A lysine-free mutant of epidermal growth factor as targeting moiety of a targeted toxin.
Bachran C; Schneider S; Riese SB; Bachran D; Urban R; Schellmann N; Zahn C; Sutherland M; Fuchs H
Life Sci; 2011 Jan; 88(5-6):226-32. PubMed ID: 21094170
[TBL] [Abstract][Full Text] [Related]
6. Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin.
Weyergang A; Selbo PK; Berg K
J Control Release; 2006 Mar; 111(1-2):165-73. PubMed ID: 16466823
[TBL] [Abstract][Full Text] [Related]
7. Pichia pastoris as a host for secretion of toxic saporin chimeras.
Lombardi A; Bursomanno S; Lopardo T; Traini R; Colombatti M; Ippoliti R; Flavell DJ; Flavell SU; Ceriotti A; Fabbrini MS
FASEB J; 2010 Jan; 24(1):253-65. PubMed ID: 19786581
[TBL] [Abstract][Full Text] [Related]
8. The 1.4 anstroms structure of dianthin 30 indicates a role of surface potential at the active site of type 1 ribosome inactivating proteins.
Fermani S; Falini G; Ripamonti A; Polito L; Stirpe F; Bolognesi A
J Struct Biol; 2005 Feb; 149(2):204-12. PubMed ID: 15681236
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cytotoxic activity of a bifunctional chimeric protein containing a type 1 ribosome-inactivating protein and a serine protease inhibitor.
Tamburino R; Pizzo E; Sarcinelli C; Poerio E; Tedeschi F; Ficca AG; Parente A; Di Maro A
Biochimie; 2012 Sep; 94(9):1990-6. PubMed ID: 22659569
[TBL] [Abstract][Full Text] [Related]
10. The toxin component of targeted anti-tumor toxins determines their efficacy increase by saponins.
Weng A; Thakur M; Beceren-Braun F; Bachran D; Bachran C; Riese SB; Jenett-Siems K; Gilabert-Oriol R; Melzig MF; Fuchs H
Mol Oncol; 2012 Jun; 6(3):323-32. PubMed ID: 22309811
[TBL] [Abstract][Full Text] [Related]
11. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
[TBL] [Abstract][Full Text] [Related]
12. The role of the glycan moiety on the structure-function relationships of PD-L1, type 1 ribosome-inactivating protein from P. dioica leaves.
Severino V; Chambery A; Di Maro A; Marasco D; Ruggiero A; Berisio R; Giansanti F; Ippoliti R; Parente A
Mol Biosyst; 2010 Mar; 6(3):570-9. PubMed ID: 20174685
[TBL] [Abstract][Full Text] [Related]
13. P1GF-saporin fusion protein: a potential anti-angiogenic agent.
Chiaramonte R; Polizzi D; Bartolini E; Petroni D; Comi P
Anticancer Drug Des; 1997 Dec; 12(8):649-57. PubMed ID: 9448704
[TBL] [Abstract][Full Text] [Related]
14. Dianthin-EGF is an effective tumor targeted toxin in combination with saponins in a xenograft model for colon carcinoma.
von Mallinckrodt B; Thakur M; Weng A; Gilabert-Oriol R; Dürkop H; Brenner W; Lukas M; Beindorff N; Melzig MF; Fuchs H
Future Oncol; 2014 Nov; 10(14):2161-75. PubMed ID: 25471031
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in research on ribosome inactivating proteins.
Ng TB; Wong JH; Wang H
Curr Protein Pept Sci; 2010 Feb; 11(1):37-53. PubMed ID: 20201806
[TBL] [Abstract][Full Text] [Related]
16. PDZ Domain in the Engineering and Production of a Saporin Chimeric Toxin as a Tool for targeting Cancer Cells.
Giansanti F; Sabatini D; Pennacchio MR; Scotti S; Angelucci F; Dhez AC; Antonosante A; Cimini A; Giordano A; Ippoliti R
J Cell Biochem; 2015 Jul; 116(7):1256-66. PubMed ID: 25581839
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor growth by targeted toxins in mice is dramatically improved by saponinum album in a synergistic way.
Bachran C; Dürkop H; Sutherland M; Bachran D; Müller C; Weng A; Melzig MF; Fuchs H
J Immunother; 2009 Sep; 32(7):713-25. PubMed ID: 19561537
[TBL] [Abstract][Full Text] [Related]
18. Heterologous expression, purification, activity and conformational studies of different forms of dianthin 30.
Legname G; Fossati G; Monzini N; Gromo G; Marcucci F; Mascagni P; Modena D
Biomed Pept Proteins Nucleic Acids; 1995; 1(2):61-8. PubMed ID: 9346855
[TBL] [Abstract][Full Text] [Related]
19. Structures of the ribosome-inactivating protein from barley seeds reveal a unique activation mechanism.
Lee BG; Kim MK; Kim BW; Suh SW; Song HK
Acta Crystallogr D Biol Crystallogr; 2012 Nov; 68(Pt 11):1488-500. PubMed ID: 23090398
[TBL] [Abstract][Full Text] [Related]
20. Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.
Polito L; Bortolotti M; Pedrazzi M; Bolognesi A
Toxins (Basel); 2011 Jun; 3(6):697-720. PubMed ID: 22069735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
